Eur Rev Med Pharmacol Sci 2013; 17 (22): 3002-3006

Suppression of RNA interference on expression of c-myc of SKOV3 ovarian carcinoma cell line

Z.-h. Ai, J. Wang, Y.-l. Xu, X.-l. Zhu, Y.-c. Teng

Department of Obstetrics and Gynecology, Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai, China. yinchengtengycht@hotmail.com


AIM: To investigate suppression of RNA interference (RNAi) on expression of c-myc of SKOV3 ovarian carcinoma cell line.

MATERIALS AND METHODS: The c-myc -siRNA was designed and synthesized, then transfected to SKOV3 ovarian carcinoma cell lines. The cell lines were divided into four groups, including the blank control group, the siRNA transfection group, the mock transfection group and the negative control group. The expression level of c-myc mRNA and protein were detected by RT-PCR and Western blotting, respectively. The growth and proliferation of SKOV3 ovarian carcinoma cell lines were observed with CCK-8 assay.

RESULTS: After transfected with c-myc -siRNA, the expression level of c-myc mRNA and protein were down-regulated, the growth and proliferation of SKOV3 ovarian carcinoma cell line were inhibited in the siRNA transfection group. There were significant differences between the siRNA transfection group and the blank control group (p < 0.05). The silencing efficiency was 77.78%, the protein suppression rate was 67.78%, and the inhibition ratio was 56.35% by CCK-8 assay in siRNA transfection group.

CONCLUSIONS: The down-regulation of c-myc expression of SKOV3 ovarian carcinoma cell line by c-myc -siRNA can lead to the suppression of cancer cell proliferation. The small interfering RNAs technique can inhibit the proliferation of carcinoma cell by oncogene silencing.

Free PDF Download

To cite this article

Z.-h. Ai, J. Wang, Y.-l. Xu, X.-l. Zhu, Y.-c. Teng
Suppression of RNA interference on expression of c-myc of SKOV3 ovarian carcinoma cell line

Eur Rev Med Pharmacol Sci
Year: 2013
Vol. 17 - N. 22
Pages: 3002-3006